Skip to main content
Log in

Comparison of Pre- and Post-transplant Parathyroidectomy in Renal Transplant Recipients and the Impact of Parathyroidectomy Timing on Calcium Metabolism and Renal Allograft Function: A Retrospective Single-Center Analysis

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The effect of parathyroidectomy (PTx) timing on serum calcium (Ca) levels and renal functions in renal transplant recipients with severe hyperparathyroidism (HPT) remains unclear. We retrospectively aimed to investigate and compare the clinical data of patients who underwent pre- and post-transplant PTx and elucidated the impact of PTx timing on serum Ca levels and renal graft outcomes after renal transplantation (RTx).

Methods

During January 2000–December 2016, 53 and 55 patients underwent post-transplant PTx (Post-RTx group) and pretransplant PTx (Pre-RTx group), respectively. The serum Ca levels and estimated glomerular filtration rate (eGFR) were assessed in both groups.

Results

At the end of the follow-up, the serum Ca levels were significantly higher and the incidence of hypocalcemia was significantly lower in the Pre-RTx group than in the Post-RTx group [9.5 vs. 8.9 mg/dL, P < 0.001; 14.5% vs. 34.0%, P = 0.024]. The decrease in the eGFR 12–36 months after RTx was more significant in the Post-RTx group than in the Pre-RTx group (−13.8% vs. −0.9%; P = 0.001). A logistic regression involving age, sex, dialysis period, and serum parathormone level revealed that post-transplant PTx is an independent risk factor for persistent hypocalcemia at the end of the follow-up (P = 0.034) and for a >20% decrease in the eGFR 12–36 months after RTx (P = 0.029).

Conclusions

In renal transplant candidates with severe HPT, pretransplant PTx should be considered to prevent persistent hypocalcemia and deterioration of the renal graft function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218

    Article  CAS  Google Scholar 

  2. Reinhardt W, Bartelworth H, Jockenhövel F et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transpl 13:436–442

    Article  CAS  Google Scholar 

  3. Pihlstrøm H, Dahle DO, Mjøen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351–359

    Article  Google Scholar 

  4. Bleskestad IH, Bergrem H, Leivestad T et al (2014) Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transpl 28:479–486

    Article  CAS  Google Scholar 

  5. Evenepoel P, Claes K, Kuypers DR et al (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transpl 22:1730–1737

    Article  Google Scholar 

  6. Schwarz A, Rustien G, Merkel S et al (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transpl 22:584–591

    Article  Google Scholar 

  7. Evenepoel P, Claes K, Kuypers D et al (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transpl 20:1714–1720

    Article  CAS  Google Scholar 

  8. Littbarski SA, Kaltenborn A, Gwiasda J et al (2018) Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery 163:373–380

    Article  Google Scholar 

  9. Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25:1248–1256

    Article  Google Scholar 

  10. Guideline Working Group, Japanese Society for Dialysis therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism. Ther Apher Dial 6:514–525

    Article  Google Scholar 

  11. Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transpl 14:272–283

    Article  CAS  Google Scholar 

  12. Matsuo S, Imai E, Horio M et al (2009) Revised Equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan. Am J Kidney Dis 53:982–992

    Article  CAS  Google Scholar 

  13. Cruzado JM, Moreno P, Torregrosa JV et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494

    Article  CAS  Google Scholar 

  14. Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2484–2494

    Google Scholar 

  15. Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359

    Article  Google Scholar 

  16. Lee HH, Kim AJ, Ro H et al (2016) Sequential changes of vitamin D level and parathyroid hormone after kidney transplantation. Transpl Proc 48:897–899

    Article  CAS  Google Scholar 

  17. Slatopolsky E, Finch J, Clay P et al (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753–761

    Article  CAS  Google Scholar 

  18. Åkerström G, Stålberg P, Surgical Management of Multiglandular Parathyroid Disease (2013) In: Randolph G (ed) Surgery of the thyroid and parathyroid glands, 2nd edn. Elsevier, Philadelphia, pp 620–638

    Google Scholar 

  19. Benz RL, Schleifer CR, Teehan BP et al (1989) Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int. 9:285–288

    CAS  PubMed  Google Scholar 

  20. Gutierrez O, Isakova T, Rhee E et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205–2215

    Article  CAS  Google Scholar 

  21. Saito H, Kusano K, Kinosaki M et al (2003) Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278:2206–2211

    Article  CAS  Google Scholar 

  22. Hsu CH, Patel SR, Young EW et al (1994) The biological action of calcitriol in renal failure. Kidney Int 46:605–612

    Article  CAS  Google Scholar 

  23. Hamdy NA, Kanis JA, Beneton MN et al (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358–363

    Article  CAS  Google Scholar 

  24. Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol Dial Transpl 19:870–876

    Article  CAS  Google Scholar 

  25. Coyne D, Acharya M, Qiu P et al (2006) Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47:263–276

    Article  CAS  Google Scholar 

  26. Tominaga Y, Matsuoka S, Uno N et al (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34:1312–1317. https://doi.org/10.1007/s00268-010-0412-9

    Article  PubMed  Google Scholar 

  27. Dreyer P, Ohe MN, Santos LM et al (2016) Parathyroid responsiveness during hypocalcemia after total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism. J Bras Nefrol 38:183–190

    Article  Google Scholar 

  28. Massfelder T, Parekh N, Endlich K et al (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118:1995–2000

    Article  CAS  Google Scholar 

  29. de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551

    Article  Google Scholar 

  30. Andreev E, Koopman M, Arisz L (1999) A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 246:247–252

    Article  CAS  Google Scholar 

  31. Parikh S, Nagaraja H, Agarwal A et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transpl 27:397–402

    Article  Google Scholar 

  32. Rosen S, Greenfeld Z, Bernheim J et al (1990) Hypercalcemic nephropathy: chronic disease with predominant medullary inner stripe injury. Kidney Int 37:1067–1075

    Article  CAS  Google Scholar 

  33. Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17:87–94

    Google Scholar 

  34. Henegar JR, Coleman JP, Cespedes J et al (2003) Glomerular calcification in hypercalcemic nephropathy. Arch Pathol Lab Med 127:80–85

    Google Scholar 

  35. Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911

    Article  Google Scholar 

  36. Yamamoto T, Tominaga Y, Okada M et al (2016) Characteristics of persistent hyperparathyroidism after renal transplantation. World J Surg 40:600–606. https://doi.org/10.1007/s00268-015-3314-z

    Article  PubMed  Google Scholar 

  37. Evenepoel P, Claes K, Kuypers D et al (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transpl 19:1281–1287

    Article  CAS  Google Scholar 

  38. Evenepoel P, Kuypers D, Maes B et al (2001) Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. Acta Otorhinolaryngol Belg 55:17–186

    Google Scholar 

  39. Nakai K, Fujii H, Ishimura T et al (2017) Incidence and Risk Factors of Persistent Hyperparathyroidism After Kidney Transplantation. Transplant Proc. 49:53–56

    Article  CAS  Google Scholar 

  40. Kikumori Imai T, Tanaka Y et al (1999) Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125:504–508

    Article  CAS  Google Scholar 

  41. Schneider R, Ramaswamy A, Slater EP et al (2012) Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? World J Surg 36:2598–2604. https://doi.org/10.1007/s00268-012-1730-x

    Article  PubMed  Google Scholar 

  42. Tominaga Y, Katayama A, Sato T, et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 18 Suppl 3:iii65–70

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Ms. Miho Miyazawa and Ms. Naoko Imai for valuable sample collection and Enago (www.enago.jp) for the English language review.

Funding

This study was not funded.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manabu Okada.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Human rights

The study protocol was approved by the Institutional Review Board of Nagoya Daini Red Cross Hospital and was conducted according to the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all individual participants included in this study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This paper will be presented as an oral presentation at the IAES meeting/48th World Congress of Surgery August 11–15, 2019, in Kraków, Poland.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okada, M., Hiramitsu, T., Ichimori, T. et al. Comparison of Pre- and Post-transplant Parathyroidectomy in Renal Transplant Recipients and the Impact of Parathyroidectomy Timing on Calcium Metabolism and Renal Allograft Function: A Retrospective Single-Center Analysis. World J Surg 44, 498–507 (2020). https://doi.org/10.1007/s00268-019-05124-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-019-05124-6

Navigation